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Granular cell tumor (GCT) was ﬁrst described by Abrikossof in 1926. This tumor is a benign neoplasm of unclear histogenesis
that is generally believed to be of nerve sheath origin. GCT is not common and most often aﬀects the tongue, skin, and soft tissue,
although it may occur anywhere in the body. Gastrointestinal tract involvement, and especially that of the colon, is very rare.
This usually benign tumor appears as a submucosal nodule, measuring less than 2cm in diameter and is often found incidentally
during colorectal examinations. We describe the case of a 27-year-old man with a GCT in the cecum that was detected after
a screening colonoscopy. Endoscopic examination revealed a yellowish submucosal tumor, 0.7cm in diameter. An endoscopic
mucosal polypectomy was done for histological conﬁrmation and treatment.
1.Introduction
Granular cell tumor (GCT) is a benign tumor with un-
known histogenesis that is characterized by large granular
eosinophilic cells [1]. GCT was ﬁrst described by Abrikossoﬀ
in 1926, [2] as a muscle tumor, and several cases have been
reported since then, but gastrointestinal tract involvement,
andespeciallythatofthecolon,isveryrare[3,4].Afewcases
of GCT have been reported in the cecum.
Instead, these tumors tend to be found incidentally dur-
ing colonoscopic examinations performed for other reasons,
as they are frequently asymptomatic. Endoscopically, a GCT
usually appears as a small submucosal nodule, measuring
less than 2cm in diameter [4–7]. In the present paper, we
describe a rare case involving a 27-year-old man diagnosed
with a GCT arising in the cecum. The tumor was resected
by endoscopic mucosal resection (EMR) for histological
conﬁrmation and treatment.
2.CaseReport
A 27-year-old man was admitted to the Gastrointestinal
Department of Hassan II University Hospital with abdomi-
nalpainanddiarrhea.Colonoscopyrevealedapolypoidmass
measuring approximately 0.7cm in diameter (Figure 1). An
endoscopic mucosal polypectomy was done for histological
conﬁrmation and treatment.
In the cecum, a submucosal tumor was identiﬁed that
was composed of solid masses of plump histiocyte-like
cells with abundant granular eosinophilic cytoplasm with
centrally located vesicular or dark pyknotic nuclei. In some
areas, a slightly nodular architecture was identiﬁed. These
nodules or sheets were surrounded by variable stroma
(Figure 2). The granules observed in the cell cytoplasm
stained positive with periodic acid-Schiﬀ (PAS). Immuno-
histochemical analysis showed that the tumor cells expressed
S-100 protein as well (Figure 3). During a 3-year followup,
he has been well without disease recurrence.
3. Discussion
GCT is a rare tumor that usually appears as a solitary,
small, nodular growth, and it follows a benign course. While
GCTs may occur at any site of the body, they are most
frequently detected in the oral cavity, skin, and subcutaneous
tissue [8]. In the gastrointestinal tract, where GCTs are
uncommon,theesophagusisthemostfrequentsite,followed
by the colon and stomach [7]. Colorectal GCTs may be
located anywhere between in the colon. However, the most
commonlocationsforcolorectalGCTsstatedintheliterature
including approximately 130 cases of colorectal GCTs are the
rectumandcecum[9].Thetumorsusuallypresentassolitary
submucosal lesions, but a multifocal disease limited to the2 ISRN Gastroenterology
Figure 1: Endoscopic photograph demonstrating a yellowish
submucosal tumor in the cecum.
Figure 2: Low magniﬁcation view of submucosal tumor arranged
in nodules and sheets (H&E ×4).
gastrointestinal tract or involving extragastrointestinal sites
has been described, representing 10% to 20% of all GCTs
[6, 7].
Most GCTs of the gastrointestinal tract are submucosal
and thus are covered by normal mucosa [4]. GCTs are
generally not large, being mostly between 1 and 2cm in
diameter; the largest reported lesion was 4cm [8]. Therefore,
these tumors are generally found incidentally. Endoscopy
demonstrates a yellowish, submucosal tumor that is usually
without mucosal ulceration and has a slightly rough surface
[8, 10]. Recently, endoscopic ultrasonography (EUS) has
been used more frequently to determine the depth of tumor
invasion in the gastrointestinal wall, and it is useful for
Figure 3: Histological ﬁndings of the tumor showing positive
immunoreaction for S-100 protein (immunohistochemical stain ×
400).
evaluating gastrointestinal tract submucosal tumors [11].
However, EUS cannot suﬃciently distinguish a benign
submucosal tumor from other tumors such as malignant
neoplasia [12].
TheﬁnaldiagnosisofGCTdependsonpathologicalﬁnd-
ings. These tumors display three main architectural patterns,
including small and well-circumscribed nodules, larger and
poorly circumscribed lesions, and an impressive inﬁltrative
pattern with remote satellite nodules. Neoplastic cells are
plumphistiocytelike,andblandlookingwithabundantgran-
ular eosinophilic cytoplasm containing acidophilic, PAS-
positive,diastase-resistantgranules;small,uniformnuclei,in
which mitotic ﬁgures are absent; neural markers, including
S-100 protein or NSE, expressed uniformly [13, 14].
The histogenesis of GCT has remained enigmatic in spite
of a vast number of immunohistochemical and ultrastruc-
tural studies. Positivity for S-100 and nestin, also seen in
gastrointestinal stromal tumors and schwannomas, suggests
Schwann cell or Cajal cell derivation [14].
Neural origin or diﬀerentiation, in particular of the
Schwann cell type, is currently in favor. However, recent
ﬁndingshavecastdoubtontheneuraloriginofthesetumors.
Vered et al. [15] have suggested that immunoreactivity of the
granular cells to a broad panel of antibodies including S-100
protein, CD68, vimentin, calretinin, NKI/C3, protein gene
product9.5,nervegrowthfactorreceptor,andinhibin-Athat
characterize diﬀerent tissues does not conﬁrm any particular
cell type for the histogenesis of GCT. They suggested that
the lesions may be metabolic or reactive in nature and
nonneoplastic.
Malignant GCTs have been described but are extremely
uncommon, representing 1% to 2% of all GCTs [16]. Only a
fewcasereportshavebeenpublishedongastrointestinaltract
involvement; however, no colonic examples were recorded.
Clinically, malignancy is suggested by GCTs rapid growth,
size greater than 4cm, and invasion of the adjacent organ.
Despite the histologic similarity observed in benign and
malignant GCTs, Fanburg-Smith et al. [17] proposed micro-
scopic criteria to classify and predict the malignant potential
of GCTs. These include necrosis, vesicular nuclei with large
nucleoli, brisk mitotic activity (>2p e r1 0h i g hp o w e rﬁ e l d s
at 200 magniﬁcation), high nuclear to cytoplasmic ratio,
nuclear pleomorphism, and spindling. Neoplasms meetingISRN Gastroenterology 3
at least 3 or more of these criteria were classiﬁed as
histologically malignant; if 1 or 2 criteria are identiﬁed,
then the tumors are classiﬁed as atypical, and those that
displayedonlyfocalnuclearpleomorphismbutfulﬁllednone
of the other criteria were classiﬁed as benign. Malignant
potential has not been reported with colonic GCTs. Thus,
patients are managed conservatively, with polypectomy for
tumors less than 4cm and segmental colectomy for larger
masses. Endoscopic mucosal resection using a transparent
cap has also been advocated. Its ease of use in submucosal
dissectionallowsforclearmargins,whileminimizingtherisk
of perforation [18].
Although endoscopic resections of colorectal GCTs are
curative in most cases, local recurrence has also been
reported [8]. Evaluation of lateral and deep margins is
needed to prevent recurrence.
Follow-up colonoscopic examination is necessary when
the tumors are multiple or a risk of malignancy exists. In
addition, endoscopic examination should include a baseline
gastroscopytoexcludethepresenceofGCTsintheesophagus
and the stomach, which are the other sites in the gastroin-
testinal tract where GCTs can be found.
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